FungiScope - A Global Emerging Fungal Infection Registry

Recruiting

• Conditions: Invasive Fungal Disease

• Registration Number: NCT01731353
• Lead Sponsor: University of Cologne

Brief Summary

The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.

Detailed Description

The specific objectives are:

1. To determine the fungal species causing invasive fungal infection in different parts of the world.

2. To determine the clinical pattern of disease and document procedures performed for confirmation of the diagnosis.

3. To describe the therapeutic regimens used and their efficacy.

4. To share clinical isolates among the contributors of Fungiscope.

5. To develop molecular biology tools for identification of strains in histopathologically proven invasive fungal infection.

Study Timeline

• Study Start: 2003-03
• Study First Submitted: 2012-11-15
• Study First Submitted QC: 2012-11-15
• Study First Posted: 2012-11-21
• Status Verified: 2023-12
• Last Update Submitted: 2023-12-04
• Last Update Posted: 2023-12-05
• Primary Completion: 2026-12
• Study Completion: 2026-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Cultural, histopathological, antigen or DNA evidence of invasive fungal infection

Exclusion Criteria

• Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jiroveci
• Endemic fungal infection such as coccidioidomycosis or histoplasmosis
• Colonisation or other non-invasive infection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Treatment efficacy of emerging fungal infections	At 90 days from diagnosis	failure, stable disease, partial response or complete response

Trial Locations

Locations (1)

University Hospital Cologne; 🇩🇪 Cologne, NRW, Germany